Introduction
The immune system is a complex network of cells, tissues, and organs that work together to defend the body against harmful pathogens(disease-causing micro-organisms) and abnormal cells(due to infection, genetic mutation, injury or cancer). Innate immune cells are at the forefront of this defence, providing rapid and non-specific responses to potential threats. Among these, we will discuss Natural Killer cells, Innate Lymphoid Cells, and Innate-Like Lymphoid Cells which play crucial roles in maintaining immune homeostasis and mounting effective immune responses. This article explores these cell types’ unique functions and mechanisms in immunity.
Natural Killer (NK) Cells
Natural Killer cells are cytotoxic(kill cells of micro-organisms or infected cells) lymphocytes that form an important component of the innate immune system. They can rapidly recognise and eliminate virus-infected, stressed, and tumour cells without prior sensitisation(interaction).1
Origin and development
NK cells originate from hematopoietic stem cells in the bone marrow. They can circulate in the blood and reside in various tissues, including the spleen, liver, and lymph nodes.1
Recognition
- NK cells utilise an equilibrium of activating and inhibitory receptors to identify abnormal cells.2 This equilibrium is crucial for NK cell function and self-tolerance:
Inhibitory receptors
- Recognise MHC class I molecules in healthy cells, preventing NK cell activation against normal self-cells2
- Signal through immunoreceptor tyrosine-based inhibitory motifs (ITIMs) in their cytoplasmic tails3
- Recruit phosphatases like SHP-1 and SHP-2 to suppress activating signals3
Activating receptors
- Recognise stress-induced ligands(signalling molecule), pathogen-associated molecules, or antibody-coated cells2
- Include receptors like NKG2D, natural cytotoxicity receptors (NCRs), and CD163
- Often requires synergistic activation of multiple receptors to trigger NK cell responses3
Integration of signals
- NK cells integrate signals from both activating and inhibitory receptors2
- Healthy cells expressing normal levels of MHC class I are protected from NK cell attack2
- Abnormal cells (e.g., tumour or virus-infected cells) often downregulate MHC class I and upregulate stress ligands, shifting the equilibrium towards NK cell activation2
This equilibrium system allows NK cells to effectively target abnormal cells while maintaining tolerance to healthy self-tissues.2
Mechanisms of action
NK cells employ several strategies to eliminate target cells:
- Cytotoxicity:
Upon activation, NK cells release cytotoxic granules containing perforin and gransymes. Perforin creates pores in the target cell membrane, allowing granzymes to enter and initiate apoptosis(mechanism of cell death).4
- Cytokine secretion:
NK cells produce pro-inflammatory cytokines like IFN-γ and TNF-α, enhancing the overall immune response.4
Role in immunity
NK cells play vital roles in:
- Viral infections: They rapidly respond to virus-infected cells, limiting viral spread
- Tumour surveillance: NK cells recognise and eliminate transformed cells, providing a first line of defence against cancer4
- Bacterial infections: NK cells control certain bacterial pathogens through cytokine production and direct cytotoxicity4
NK cells in immune regulation
NK cells interact with other immune cells, such as dendritic cells and T cells, influencing the overall immune response. They also play a role in maintaining tissue homeostasis(composition) and regulating inflammation.1
Innate Lymphoid Cells (ILCs)
Innate Lymphoid Cells are a group of innate immune cells that lack antigen-specific receptors. They play similar roles in innate immunity compared to T-helper cells in adaptive immunity.
Development and differentiation
ILCs develop from common lymphoid progenitors in the bone marrow. Their differentiation is influenced by specific cytokines and transcription factors.5
Mechanisms of action
ILCs primarily function through cytokine production and interaction with other immune cells. They respond rapidly to environmental cues and play crucial roles in tissue homeostasis and immunity.5
They are classified into three main groups based on their cytokine production and transcription factors:
- Group 1 ILCs (ILC1s)
- Group 2 ILCs (ILC2s)
- Group 3 ILCs (ILC3s)
Role of Group 1 ILCs (ILC1s)
ILC1s are similar to NK cells in function and respond to intracellular pathogens by producing IFN-γ.6
Role of Group 2 ILCs (ILC2s)
ILC2s are involved in:
- Allergic responses and asthma6
- Tissue repair6
- Immune responses against helminths6
Role of Group 3 ILCs (ILC3s)
ILC3s contribute to:
- Defence against extracellular bacteria6
- Maintenance of mucosal integrity6
- Development and function of gut-associated lymphoid tissue (GALT)6
- ILCs in Immune Regulation6
- ILCs interact with the microbiota, maintain tissue homeostasis, and influence autoimmune diseases and inflammation.6
Innate-Like Lymphoid Cells (ILLCs)
Innate-like lymphoid Cells (ILLCs) are a group of immune cells that share innate and adaptive immunity characteristics. They are found in various tissues and respond rapidly to local stimuli. They are distinct from but related to ILCs and NK cells.7
Types of Innate-Like Lymphoid Cells
Key Characteristics of ILLCs
- Hybrid features of innate and adaptive immunity:
ILLCs exhibit rapid effector functions typical of innate immune cells while possessing limited clonal diversity and the ability to generate memory responses, which are characteristics of adaptive immunity.7
- Presence in tissues and local microenvironments:
ILLCs are enriched in various tissues, allowing them to respond quickly to local immune challenges.7
Role in Immunity
- Surveillance against infections:
ILLCs play a crucial role in monitoring and responding to various pathogens, including viruses, bacteria, and fungi.71. NKT cells recognise lipid antigens presented by CD1d molecules which can be expressed on tumor cells.8
- Tumor immunity:
ILLCs contribute to anti-tumor responses through direct cytotoxicity, cytokine production, and modulation of the tumor microenvironment. MAIT cells recognise microbial metabolites associated with various pathogens and tumors, potentially contributing to anti-tumor responses.8
- Modulation of autoimmune diseases:
ILLCs can influence the development and progression of autoimmune conditions through their interactions with other immune cells and tissues.7 γδ T cells exhibit cytotoxic activity against various tumor types and produce pro-inflammatory cytokines.8
- Regulation of Innate and Adaptive Immunity
Interaction with antigen-presenting cells (APCs): ILLCs interact with APCs, influencing the initiation and modulation of adaptive immune responses.7 Bridging the gap between innate and adaptive immune responses: ILLCs possess characteristics of both innate and adaptive immunity, allowing them to facilitate communication between these two arms of the immune system.7
Cross-talk Between NK Cells, ILCs, and ILLCs
NK cells, ILCs, and ILLCs work together to mount effective immune responses against various threats, sharing some functions and differentiation signals. They mutually influence tissue microenvironments and play roles in inflammation and immunopathology.9
Shared Functions and Differentiation Signals
These cell types often share common progenitors and differentiation pathways. For example, NK cells and ILC1s express T-bet and produce IFN-γ in response to similar stimuli.9
Mutual Influence on Tissue Microenvironments
NK cells, ILCs, and ILLCs can influence the local tissue environment through cytokine production and interactions with other immune cells. This mutual influence shapes the overall immune response in specific tissues.10
Role in Inflammation and Immunopathology
While these cells play crucial roles in protective immunity, their dysregulation can contribute to inflammatory conditions and immunopathology. Understanding their interactions is essential for developing targeted therapies.10
Clinical Implications and Therapeutic Potential
Modulating NK Cell and ILC Function in Disease
Cancer immunotherapy:
NK cells and ILCs have shown promise in cancer immunotherapy, particularly in haematological malignancies.2
Autoimmune diseases:
Targeting NK cells and ILCs may help modulate autoimmune responses and reduce inflammation in various autoimmune conditions.10
Chronic infections and inflammatory conditions:
Modulating the function of these cells could potentially help manage chronic infections and inflammatory disorders.10
Targeting ILLCs in Immunotherapy
ILLCs, particularly NKT cells and γδ T cells, are being explored as potential targets for cancer immunotherapy due to their ability to recognise tumor-associated antigens and produce anti-tumor cytokines.8
Challenges and Future Directions in Immunological Research
Future research should focus on better understanding the complex interactions between NK cells, ILCs, and ILLCs in various disease contexts. Developing strategies to selectively modulate these cell types while minimising off-target effects remains a significant challenge in immunotherapy.2
Conclusion
NK cells, ILCs, and ILLCs are crucial components of the innate immune system, playing vital roles in maintaining immune homeostasis and responding to infections. As our understanding of these cells and their interactions evolves, new therapeutic strategies targeting these cell types may emerge, potentially revolutionising the treatment of various diseases.
Modulating the functions of NK cells, ILCs, and ILLCs holds promise for various therapeutic applications, including cancer immunotherapy, treating autoimmune diseases, and managing chronic infections and inflammatory conditions.
References
- Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nature Immunology. 2008;9(5): 503–510. Available from: https://doi.org/10.1038/ni1582.
- Paul S, Lal G. The molecular mechanism of natural killer cells function and its importance in cancer immunotherapy. Frontiers in Immunology. 2017;8. Available from: https://doi.org/10.3389/fimmu.2017.01124.
- Kumar S. Natural killer cell cytotoxicity and its regulation by inhibitory receptors. Immunology. 2018;154(3): 383–393. Available from: https://doi.org/10.1111/imm.12921.
- Letafati A, Ardekani OS, Naderisemiromi M, Norouzi M, Shafiei M, Nik S, et al. Unraveling the dynamic mechanisms of natural killer cells in viral infections: insights and implications. Virology Journal. 2024;21(1): 18. Available from: https://doi.org/10.1186/s12985-024-02287-0.
- Hazenberg MD, Spits H. Human innate lymphoid cells. Blood. 2014;124(5): 700–709. Available from: https://doi.org/10.1182/blood-2013-11-427781.
- Xiong L, Nutt SL, Seillet C. Innate lymphoid cells: More than just immune cells. Frontiers in Immunology. 2022;13. Available from: https://doi.org/10.3389/fimmu.2022.1033904.
- Van Kaer L, Postoak JL, Song W, Wu L. Innate and innate-like effector lymphocytes in health and disease. The Journal of Immunology. 2022;209(2): 199–207. Available from: https://doi.org/10.4049/jimmunol.2200074.
- Yuan X, Rasul F, Nashan B, Sun C. Innate lymphoid cells and cancer: Role in tumor progression and inhibition. European Journal of Immunology. 2021;51(9): 2188–2205. Available from: https://doi.org/10.1002/eji.202049033.
- Sugimura R, Wang CY. The role of innate lymphoid cells in cancer development and immunotherapy. Frontiers in Cell and Developmental Biology. 2022;10: 803563. Available from: https://doi.org/10.3389/fcell.2022.803563.
- Bruchard M, Ghiringhelli F. Deciphering the roles of innate lymphoid cells in cancer. Frontiers in Immunology. 2019;10: 656. Available from: https://doi.org/10.3389/fimmu.2019.00656.

